Carnie Wilson, co-founder of Wilson Phillips, discussed her mental health journey and how this brought her in touch with ...

It is estimated that 40% of obsessive compulsive disorder (OCD) sufferers do not respond adequately to standard treatments.

COMPASS Pathways focuses on developing COMP360 psilocybin for treatment-resistant depression. Click here to read an analysis ...

IRRITABLE, moody, low energy, emotionally withdrawn, snappy, quiet, stressed, angry…  If any of these labels apply to the man in your life, they could be suffering from ‘miserable husband ...

Q: I recently had to have additional surgery after a total knee replacement. Nothing the hospital gave me for pain helped at all. My neighbor told me that after her surgery, she had the same ...

Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 American Society of ...

A variety of antidotes have been reported to treat SSRI-induced sexual dysfunction effectively; however, virtually all the data on these agents are derived from open case reports and case series ...